FindTrial
Sign In

To investigate the effective doses of fentanyl in inhibiting cardiovascular response of double-lumen bronchial intubationIn different genders

To investigate the effective doses of fentanyl in inhibiting cardiovascular response of double-lumen bronchial intubationIn different genders

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024754
Enrollment
Unknown
Registered
2019-07-26
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular response to double lumen endotracheal intubation

Interventions

Case series:Fentanyl will used to inhibit the response of the double-lumen endotracheal intubation

Sponsors

The First Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Patients aged 18 to 65 years old, ASA I to II, take lung neoplasm resection under general anesthesia with double lumen endobronchial intubation.

Exclusion criteria

Exclusion criteria: 1. The patient has a history of difficult intubation, or a failed intubation in this study; 2. Having a history of opioid or other sedative drug abuse before surgery; 3. Liver, kidney or blood system diseases; 4. High-risk patients with reflux aspiration; 5. BMI>25kg/m2 or < 18kg /m2; 6. Severe cardiopulmonary disease before operation.

Design outcomes

Primary

MeasureTime frame
Mean arterial pressure;—

Countries

China

Contacts

Public ContactBo Gui

The First Affiliated Hospital of Nanjing Medical University

guibosy@163.com+86 13675163272

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026